KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Invested Capital: 2009-2025

Historic Invested Capital for Ionis Pharmaceuticals (IONS) over the last 16 years, with Sep 2025 value amounting to $1.2 billion.

  • Ionis Pharmaceuticals' Invested Capital rose 76.66% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 76.66%. This contributed to the annual value of $588.4 million for FY2024, which is 36.50% up from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Invested Capital stood at $1.2 billion, which was down 1.03% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Invested Capital peaked at $1.3 billion during Q2 2025, and registered a low of $308.1 million during Q2 2024.
  • In the last 3 years, Ionis Pharmaceuticals' Invested Capital had a median value of $475.7 million in 2025 and averaged $599.3 million.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Invested Capital slumped by 63.25% in 2021, and later skyrocketed by 309.53% in 2025.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Invested Capital stood at $775.3 million in 2021, then fell by 26.10% to $572.9 million in 2022, then declined by 24.76% to $431.0 million in 2023, then surged by 36.50% to $588.4 million in 2024, then surged by 76.66% to $1.2 billion in 2025.
  • Its Invested Capital stands at $1.2 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $475.7 million for Q1 2025.